This is just a note that I bought some shares of Biogen-Idec (BIIB) this morning after listening to the analyst conference for Q4 2007. This should not be a surprise to anyone who has been reading this column, given my past comments and the strong results for the quarter.
To learn more you can:
Read my summary of the February 6, 2008 Biogen-Idec analyst conference
Find more links to summaries and blogs at my Biogen-Idec main page
Read my blog, Choosing a Biotech Stock 3: Biogen Idec [September 14, 2007]
Today I am also going to be listening to analyst conferences of Akamai, Cisco, Napster and Rack, so it will be a busy day.